Results for tag: "Adenosine Triphosphate Assays"

Adenosine triphosphate (ATP) assays play a crucial role in the field of endocrine and metabolic disorders drugs, providing a valuable tool for researchers to measure cellular energy levels and assess mitochondrial function. Since endocrine and metabolic diseases often involve alterations in cellular metabolism and energy utilization, ATP assays are employed to investigate the efficacy and mechanism of action of therapeutic drugs. These assays can help identify compounds that normalize ATP production or consumption, which may be indicative of restored metabolic function in diseased cells. In the context of drug discovery and development for endocrine and metabolic disorders, ATP assays are utilized in high-throughput screening to evaluate the metabolic activity of cells in response to various drug candidates. They are also used in preclinical studies to measure the bioenergetic health of cells and to understand drug-induced changes in metabolic pathways. Additionally, ATP assays assist in diagnosing mitochondrial disorders, which are often associated with endocrine abnormalities such as diabetes and thyroid dysfunction, by detecting deficiencies in cellular energy production. Companies that operate within the ATP assays market often provide a range of products, including assay kits, reagents, and instruments designed for both research and clinical uses. Some of these companies include: - Merck (Sigma-Aldrich) - Thermo Fisher Scientific - Promega Corporation - BioVision, Inc. - Abcam plc - Cell Biolabs, Inc. - Bioluminescent reagents and instruments from companies like Molecular Devices - Various other life sciences and biotechnology firms that Show Less Read more